Happy New Year from MSIP!
Mount Sinai Innovation Partners
Hospitals and Health Care
New York, NY 5,983 followers
Bringing the Mount Sinai Health System's discoveries to life
About us
Mount Sinai Innovation Partners (MSIP), the technology commercialization arm of the Mount Sinai Health System, facilitates the transfer of discovery from the laboratory to the marketplace, acting as the interface with commercial entities. MSIP is responsible for the full spectrum of commercialization activities required to bring Mount Sinai's inventions to life. These activities include evaluating, patenting, marketing, and licensing new technologies, while also negotiating agreements for sponsored research, material transfer, and confidentiality.
- Website
-
https://ip.mountsinai.org/
External link for Mount Sinai Innovation Partners
- Industry
- Hospitals and Health Care
- Company size
- 51-200 employees
- Headquarters
- New York, NY
- Type
- Nonprofit
- Specialties
- technology transfer, startups, intellectual property management, licensing, healthcare, medical innovation, education, research innovation, technology development, commercialization, entrepreneurship, and accelerator
Locations
-
Primary
Get directions
150 East 42nd St.
2nd Floor
New York, NY 10017, US
Employees at Mount Sinai Innovation Partners
-
Samuel R. Tepper, PhD
Proud Dad / Founder / Builder / Mentor / Growth Advisor / Enablement / Tech / AI Evangelist / Ex-Salesforce
-
Ana Kostic
-
Alan Belicha, PhD
Life sciences business development and licensing leader with over $1.3B in transactions
-
Lisa Wisniewski, PhD
Managing Director at Global BioAccess Fund
Updates
-
GNOMX Corp., a company focused on providing specific infection diagnosis, multiple target diagnosis, and antibiotic sensitivity based on technology developed at the Icahn School of Medicine at Mount Sinai, was awarded a $749,700 contract by the Division of Research, Innovation, and Ventures (DRIVe) within the Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Department of Health and Human Services (HHS). Learn more: https://lnkd.in/eUr-sanq
-
Fanny Elahi, MD, PhD, physician-scientist and Associate Professor of Neurology, Neuroscience, and Pathology, Molecular and Cell-Based Medicine at the Icahn School of Medicine at Mount Sinai, discusses her research regarding blood biomarkers of angiogenesis and cognitive decline in women. Learn more: https://lnkd.in/eeSTUbhU
The Brain's Blood Vessels May Be Driving Cognitive Decline in Women
https://www.beingpatient.com
-
Kick off 2025 with innovation news at Mount Sinai! Sign up here for The Innovation Exchange and you'll receive updates, events, and the quarterly newsletter from MSIP! https://lnkd.in/dWtzPyb
Mount Sinai Innovation Partners
mountsinai.us6.list-manage.com
-
Girish Nadkarni, MD, Professor of Medicine at the Icahn School of Medicine at Mount Sinai, discusses his research regarding a novel artificial intelligence-driven tool that predicts intracranial hypertension quickly. Learn more: https://lnkd.in/e4KTUXQp
AI Tool for Predicting Intracranial Hypertension May Lead... : Neurology Today
journals.lww.com
-
GNOMX Corp., a company focused on providing specific infection diagnosis, multiple target diagnosis, and antibiotic sensitivity based on technology developed at the Icahn School of Medicine at Mount Sinai, was awarded a $749,700 contract by the Division of Research, Innovation, and Ventures (DRIVe) within the Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Department of Health and Human Services (HHS). Learn more: https://lnkd.in/eUr-sanq
GNOMX Corp. awarded phase 1 BARDA DRIVe contract to develop immune dysregulation host-based assay for predicting sepsis patient readmission risk
eurekalert.org
-
Fanny Elahi, MD, PhD, physician-scientist and Associate Professor of Neurology, Neuroscience, and Pathology, Molecular and Cell-Based Medicine at the Icahn School of Medicine at Mount Sinai, discusses her research regarding blood biomarkers of angiogenesis and cognitive decline in women. Learn more: https://lnkd.in/eeSTUbhU
The Brain's Blood Vessels May Be Driving Cognitive Decline in Women
https://www.beingpatient.com
-
Are you interested in a career focused on educating innovators in entrepreneurship, National Science Foundation (NSF) I-Corps methodology, and startup activities for the Mount Sinai Health System? MSIP is hiring a Program Manager! Learn more: https://lnkd.in/epvqFAvW
Program Manager - Education & Entrepreneurship/Innovation in New York, NY | Mount Sinai Health Systems
careers.mountsinai.org
-
Explore the MSIN site! Our mission is to discover and develop leading-edge innovations! Connect with us today to learn more about specific research, technologies, and opportunities. https://lnkd.in/eX6xnvAQ
-